Who you will help

Cancer is universally devastating news. Regardless of culture or language, the life-altering diagnosis comes with questions, fears, and hope. Cancer is indiscriminate, so its treatment should be too. The new Beit Shulamit Cancer Center will diagnose and provide treatment for thousands of patients, serving Jewish, Christian, Muslim and Druze communities from both Israeli and Palestinian regions. Beit Shulamit makes it possible for those living in periphery communities in northern Israel to access cancer care that were previously unavailable and inaccessible to them. The state-of-the-center will house an impressive roster of departments and research institutes, providing high-quality care and conducting world-class research. The design is uniquely integrated with the surrounding foothills, blending together building and nature, inside and outside, hospital and healing. Donation opportunities focus on providing meaningful outdoor spaces for the patients and visitors of Beit Shulamit to escape the reality of cancer treatment, if only for a moment.

Your donation will fund

A Toddler's Playground, an age-appropriate playground for children undergoing treatment of visiting loves ones. With fun hiding spots and winding tree steps, kids can explore and relax outside the walls of the hospital.

Location

Afula, just outside of Nazareth.

About Beit Shulamit Cancer Center

Beit Shulamit (Shulamit House) will be built within Emek Medical Campus in Afula. The 11,000 square meter facility and grounds will house a radiation therapy institute, breast cancer care centre, paediatric oncology department, well-being centre, infusion therapy, in-patient department, ambulatory clinics and research institute, headed by Nobel-prize-winner Prof. Aharon Chechanover. The building, designed by renowned architect Ron Arad, prioritizes natural light, gardens and outdoor spaces. Beit Shulamit is named in memory of paediatrician, philanthropist and social activist Dr. Shulamit Katzman and founded by the Katzman Family Foundation.